48 results about "Cinnamates" patented technology

The application relates to the technical field of injection molding demolding master batches, in particular to a polyester transparent injection molding demolding master batch and a preparation method and application thereof. According to mass proportions, 85% to 97% of a carrier and 3% to 15% of a lubricant are included; the lubricant includes zinc bungarotoxin, zinc cinnamate and octadecyl octadecanoate with a mass ratio of (2 to 6):(2 to 6):(1 to 4). The lubricant with the specific component ratio improves the fluidity and demolding property of the polyester product and reduces the haze.

The invention relates to the technical field of biological medicine, in particular to application of esterified derivatives of methyl p-hydroxycinnamate in preparation of antitumor drugs. Experiments show that the derivative has an obvious inhibition effect on the cell viability of tumor cells such as gastric cancer, nasopharynx cancer and breast cancer, particularly has obvious proliferation, migration and invasion inhibition ability on the gastric cancer cells, can induce apoptosis of the gastric cancer cells, has relatively low toxic and side effects, and provides a new medicine for treating the gastric cancer.

The present invention relates to a composition comprising: 1) at least one inorganic UV filter selected from titanium dioxide; 2) at least one α-cyanodiphenylacrylate derivative of the given formula; and 3) at least one 4-hydroxybenzylidenemalonate or 4-hydroxycinnamate derivative of the given formula. The present invention also relates to a cosmetic method for treating skin against UV radiation using said composition.

The invention discloses a multi-scene deodorizing detergent composition and a preparation method thereof, and relates to the technical field of daily chemical industry. The multi-scene deodorizing detergent composition provided by the invention is prepared from the following core components: alkyl glycoside, sodium lauroamphoacetate, tea saponin, hydroxypropyl-beta-cyclodextrin, chitosan, compound enzyme, sodium cinnamate, dragon fruit extract, humulus lupulus extract and the like. Through the synergistic effect of all the components, the composition realizes integration of multiple effects: the irritation is remarkably reduced and the skin barrier is maintained while efficient decontamination is realized; an adsorption-degradation system formed by hydroxypropyl-beta-cyclodextrin, chitosan and compound enzyme can radically remove peculiar smell and efficiently degrade pesticide residues; the chitosan and the pitaya extract synergistically chelate heavy metal ions; and components such as sodium cinnamate have natural whitening and broad-spectrum preservative functions. The technical limitation that a traditional product is single in function is broken through, and a comprehensive and safe washing solution with a positive skin care effect is provided.

An objective of the present invention is to provide a photosensitive organic insulating composition having sufficient absorption, even of i-line radiation, as a photosensitive organic insulating composition that has little influence on device reliability and that is capable of forming a gate insulating film for transistors. An objective of the present invention is also to provide a gate insulating film and a transistor. A photosensitive organic insulating composition according to one embodiment of the present invention contains a chalcone compound and polyvinyl cinnamate.

The present invention discloses a composition and method for treating arthritis. The composition comprises a binary blend of molecules including citral, methyl cinnamate, and epicurzerenone. The binary blend exhibits synergistic efficacy in modulating inflammatory cytokines. The citral, epicurzerenone, and methyl cinnamate, are derived from essential oils of Cymbopogon citratus, Hedychium spicatum, and Zanthoxylum armatum, respectively. Both individual and binary blend exhibits downregulation of pro-inflammatory cytokines IL-2, IL-6, and TNF-α, and upregulation of anti-inflammatory cytokine IL-10

The present invention provides matrices for use in mass spectrometry, particularly matrix-assisted laser desorption / ionization mass spectrometry techniques. Methods of use, including for imaging mass spectrometry, of the presently disclosed matrices are also provided.

A cosmetic skin care composition having a peptide derivative, a fatty acid having from about 8 to about 22 carbon atoms, and a dermatologically acceptable carrier. The peptide derivative has a formula: Rc-R1-Gly-Pro-Gln-Gly-R2, where Rc is chosen from hydroxycinnamic acid, its derivative, and mixtures thereof, where R1 and R2 are respectively from about 0 to about 8 amino acids, and wherein a total of R1 and R2 is 8 or less amino acids; The composition provides improved penetration of such peptide derivatives to skin.

This invention generally relates to the use of hydroxycinnamic acid or its derivatives, such as alginate, in cosmetic or therapeutic settings. The invention further relates to compositions comprising hydroxycinnamic acid or its derivatives.

The present invention provides a repellent composition for mites which is excellent in mite-repelling effect against indoor mites even after a long period of time and is also excellent in safety to humans and animals. The present invention relates to a repellent composition for mites, which contains: (a) 1,8-cineol and / or 1,4-cineol and (b) a perfume ingredient, wherein the perfume ingredient contains one or two or more kinds of perfume compounds having a logP value of 2.0 to 5.5. The mixing ratio (a) / (b) of the (a) ingredient to the perfume compounds contained in the (b) ingredient is set to 5 to 100 on a mass basis. The perfume compounds contained in the (b) ingredient are at least one selected from the group consisting of ethyl cinnamate, allyl caproate, 3-methyl-5-phenyl-1-pentanol, citronellol, δ-dodecalactone, β-ionone, benzyl benzoate, linalyl acetate, geranyl acetate, tricyclo decenyl propionate, benzyl salicylate, limonene, and amyl salicylate.

The present application provides use of compounds represented by formula (I) and formula (II) in the preparation of drugs for improving male reproductive ability. In the present application, different oligoasthenospermia models are constructed, and the improvement effects of the compounds represented by formula (I) and formula (II) on male reproductive ability impairment are verified by means of sperm count analysis, sperm motility analysis, mRNA expression level analysis of inflammatory and antioxidant genes, testicular histopathological damage analysis, etc. The experimental results show that the compounds represented by formula (I) and formula (II) increase the sperm count in mice with oligoasthenospermia, improve the sperm motility of the mice with oligoasthenospermia, ameliorate testicular histopathological damage in the mice, suppress the expression of inflammatory factors, and increase the expression of antioxidant genes, demonstrating great potential in the treatment of oligoasthenospermia.

This invention belongs to the field of polyether polyol synthesis technology, specifically relating to bio-based high-strength polyether ester polyols and their preparation methods. The bio-based high-strength polyether ester polyol is obtained from the following raw materials: small molecule polyol, catalyst, bio-based epoxide, and bio-based phenyl ester compound; the bio-based epoxide is one or more of limonene epoxide, α-pinene oxide, and caryophyllene oxide; the bio-based phenyl ester compound is one or two of benzyl benzoate and benzyl cinnamate. The raw materials used in this invention can be obtained through natural plant extraction, achieving full bio-based polyether ester polyol production, thus fundamentally reducing dependence on fossil resources. By introducing a large number of cyclic and benzene ring structures into the polyol molecule, the resulting product is applied in the field of rigid polyurethane foam, increasing the content of rigid groups in the molecular chain structure, and significantly improving the strength of rigid polyurethane foam compared to traditional polyether polyols.

The present invention relates to some crystal forms for a cinnamic compound, BMX, which is an inhibitor of histone deacetylase (HDAC), useful as an agent for the prevention or treatment of diseases associated with HDAC, including for treating tumor or cell proliferative diseases, diabetes mellitus, or neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, Spinocerebellar Ataxias (SCA) and human spinal muscular atrophy (SMA). Also provided are a method for preparing the crystal forms and pharmaceutical compositions comprising the crystal forms.

The application discloses a kind of strawberry wine and its brewing method, adopt first Angelus yeast SY after Angelus yeast RW fermentation after the strawberry wine aroma compound content of aging is ester > alcohol > acid > other > terpene class.SY+RW fermentation of strawberry wine aroma compound content is ester > alcohol > other > acid > terpene class, it is rich in the complexity of wine aroma, give fruit wine more elegant and unique aroma;Wherein, in the fermentation of Angelus yeast SY, the highest OAV value of isoamyl acetate is given, and the main fermentation stage of wine body presents the rich banana aroma;In the fermentation stage of Angelus yeast RW, the content of ester is more, wherein the highest OAV value of ethyl decanoate and isoamyl acetate is given, and the rich pineapple, banana aroma of post-fermentation stage of wine body is given;With the progress of fermentation, the highest OAV value of ethyl cinnamate and phenylethanol is reached, and the rose flower fragrance and sweet amber paste fragrance of strawberry wine aging stage are given, and accompanied by the original aroma of strawberry fruit.

The application belongs to the field of natural product chemistry and medicinal chemistry, and discloses 10,11-dehydrovariecolin cinnamic acid derivatives, a preparation method and purposes thereof. The preparation method takes 10,11-dehydrovariecolin from a fungus as a starting material, and the target derivative is prepared by esterification reaction of the 5-position hydroxyl group of the starting material with cinnamic acid. The series of compounds show good bacteriostatic activity and antitumor activity, and can be used for preparing antitumor drugs or antibacterial drugs.

Sunscreen-effective active ingredient combinations made up of (a) one or more cinnamic acid derivatives of formula (1a) and (1b) in which the groups X, Y and R can be chosen independently from the group hydrogen, and branched or unbranched C1-C 18 Alkyl, and (b) 4-Hydroxyacetophenone.

The application provides a fluorescent probe based on a cinnamic acid derivative as well as a synthesis method and application thereof, and relates to the technical field of synthesis of specific probes. The fluorescent probe is prepared by introducing benzyl bromide into the hydroxyl group of a modified structure compound FHA using p-hydroxycinnamic acid as raw material, and a novel bifunctional fluorescent probe capable of specifically detecting Al 3＋ and N2H4 is developed. The application overcomes the defects of the prior art, the probe can specifically detect Al 3+ and N2H4, and has the characteristics of low detection limit, short response time, wide pH application range and the like; the probe has the characteristics of good biocompatibility, small toxicity, good optical properties and the like, and can be applied to cell imaging experiments.

This invention relates to the field of biotechnology, and discloses an engineered *Yarrowia lipolytica* strain that produces p-coumaric acid using glucose as a substrate, its construction method, and its applications. Construction method: A tyrosine ammonia-lyase gene is integrated using a CRISPR / Cas9 localization and integration method. TAL In *Yarrowia lipophila* strains, the DAHP synthase gene was enhanced. ARO4 , DHS1 and AROG Overexpression of tyrosine synthase TYR Genes and histidine phosphotransferases HIS5 The protease gene was further integrated to synthesize exogenous phenylalanine deamination and hydroxylation pathway genes for p-coumaric acid, including phenylalanine ammonia-lyase gene, cinnamate hydroxylase gene, and P450 reductase gene. The p-coumaric acid produced by the engineered *Yarrowia lipolytica* strain of this invention can reach a maximum yield of 1.7 g / L in shake flasks, and a yield of 30 g / L in a 5 L fed-batch fermentation tank, demonstrating significant industrial application value.

The invention relates to the technical field of component design, in particular to a benzene ring acid group substitution type screening method based on isoamyl cinnamate and application of the benzene ring acid group substitution type screening method based on isoamyl cinnamate. The screening method comprises the steps that a virtual substituent library is established, acid group substituents are introduced to an isoamyl cinnamate benzene ring, and a plurality of substitution combinations are generated; predicting a minimum value pKai of an acid dissociation constant and a polar atom ratio PAR for each structure, and screening less than or equal to 50 candidate structures according to the minimum value pKai and the polar atom ratio PAR; measuring the fluorescence polarization anisotropy r of each candidate structure, and screening the first 50% of samples according to the sequence of r values from small to large; sequentially measuring the quantum dot fluorescence intensity retention rate Fret and the coating UVB retention rate RAUVB of the screened samples; and outputting the acid group substitution type corresponding to the maximum value according to the product sequence of the two. The self anti-ultraviolet attenuation capability and the photosensitive component protection effect are reflected, and the optimal structure is ensured to have self stability and synergistic protection performance in a real compound system.

This disclosure relates to pharmaceutical compositions useful for inhibiting the progression of a neurodegenerative disorder or glycine encephalopathy. The pharmaceutical compositions may include cinnamic acid. The pharmaceutical compositions and formulations may be orally administered to the patient.

The invention relates to the technical field of traditional Chinese medicine, and discloses acupoint massage essential oil for assisting in controlling smoke and refreshing and a preparation method of the acupoint massage essential oil. Comprising a monarch drug of galangal essential oil, a ministerial drug of lemon essential oil, an adjuvant drug of mint essential oil, an adjuvant drug of coenzyme Q10, an adjuvant drug of limonene, an adjuvant drug of linalool, an adjuvant drug of methyl cinnamate, a conductant drug of jojoba oil and a conductant drug of vanillin. Through synergistic improvement of a formula and a process, effective components of the massage essential oil enter a human body through mutual cooperation of smelling and acupoint massage, the activity of monoamine oxidase is rapidly inhibited, the fragrance is mild, the smell is pleasant, the massage essential oil is convenient to carry and use at any time, and the user experience and the psychological feeling during use are remarkably improved; when the cigarette holder is used, a user can feel pleasant during smoking, untoward effects and pains caused by smoking addiction are relieved, the number of smoking times can be gradually reduced, and the purposes of controlling smoking and quitting smoking are achieved.

This invention discloses a photosensitive resin composition for use as an alignment agent, the composition comprising: (A) a dianhydride monomer containing a photosensitive group, wherein the photosensitive group is selected from at least one of cinnamate, chalcone, anthracene, coumarin, or benzophenone; (B) a hydrogen donor diamine monomer; and (C) an aliphatic diamine monomer. This invention uses a self-initiating photosensitive resin composition to replace formulation systems relying on exogenous photoinitiators, introducing long alkyl chains into the polyimide molecular chain, which are complementary to the liquid crystal molecular structure, enhancing the interfacial anchoring energy, stabilizing the liquid crystal pretilt angle, and thus maintaining a stable display response time.

The invention relates to the technical field of cloth preparation, and provides a manufacturing process of antistatic grey cloth. The invention relates to an antistatic gray fabric which is obtained by sequentially carrying out padding treatment on a gray fabric through an antistatic finishing agent and an anti-ultraviolet finishing agent, the anti-ultraviolet finishing agent is prepared from the following components in parts by weight: 20 to 25 parts of 2-hydroxy-4-methoxy-5-benzophenone sulfonate, 5 to 6 parts of 4-methoxy isoamyl cinnamate, 15 to 18 parts of zinc oxide, 2 to 4 parts of a surfactant, 1 to 3 parts of a de-foaming agent, 3 to 6 parts of a methoxy-containing phenolic compound, 15 to 20 parts of ethanol and 80 to 85 parts of water; the phenolic compound containing the methoxy group comprises 2-methoxy-4-methylphenol and 4-ethyl-2-methoxyphenol, and the weight ratio of the 2-methoxy-4-methylphenol to the 4-ethyl-2-methoxyphenol is (1-9): 1. According to the technical scheme, the problem that the anti-ultraviolet performance of the gray fabric is poor in the prior art is solved.

The invention provides a liquid crystal aligning agent for forming a weak anchor film, a method for manufacturing a liquid crystal alignment film and a method for manufacturing a liquid crystal element. The liquid crystal alignment agent for forming a weak anchor film can form a liquid crystal alignment film for obtaining a liquid crystal element which has good liquid crystal alignment property and alignment uniformity and can be driven at a low voltage while having high brightness. The liquid crystal aligning agent for forming the weak anchor film is used for forming the weak anchor liquid crystal aligning film, and comprises a polymer (P), the polymer (P) has at least one selected from the group consisting of a specific cinnamate structure, a specific partial structure having a nitrogen-containing aromatic heterocyclic ring, an azobenzene structure, a chalcone structure, a coumarin structure, and a chromanone structure.

The invention discloses phenylalanine ammonia lyase and application of the phenylalanine ammonia lyase in preparation of S-type beta-amino acid. Compared with an amino acid sequence as shown in SEQ ID NO: 1, the amino acid sequence of the phenylalanine ammonia lyase comprises one or more amino acid residue differences in the following sites: the 147th site, the 244th site, the 251st site, the 314th site, the 333th site and the 342nd site. The S-type beta-amino acid is prepared by adopting a mutant of phenylalanine ammonia lyase from streptomyces and taking cinnamic acid or a derivative thereof as a substrate, and the regioselectivity, the enantiomer selectivity and the conversion rate of the product are all remarkably improved.

The application discloses a hydroxyl cinnamic acid alkoxyl alcohol ester derivative and application thereof in cosmetics. Specifically, the application provides a hydroxyl cinnamic acid alkoxyl alcohol ester derivative which is a compound as shown in formula I. The compound provided by the application has good oil phase solubility, high stability in a system, and one or more effects such as antioxidation, whitening and ultraviolet absorption.

A composition for inhibiting sebum secretion is disclosed. The composition contains 3,4,5-trimethoxycinnamate thymol ester, a stereoisomer, pharmaceutically acceptable salt, hydrate, or solvate thereof as an active ingredient. The composition can inhibit sebum secretion in the skin or scalp, and further has useful effects such as the prevention or improvement of seborrheic dermatitis, seborrheic scalp dermatitis, or acne, or the tightening of pores. Methods for inhibiting sebum secretion employing 3,4,5-trimethoxycinnamate thymol ester, a stereoisomer, pharmaceutically acceptable salt, hydrate, or solvate are disclosed.

The invention provides a patterned phase difference plate and a manufacturing method thereof. The patterned phase difference plate which is large in area and excellent in long-distance dimensional stability of a phase difference region is manufactured through a relatively simple method. The patterned phase difference plate is manufactured by a method including a step of applying a liquid crystal aligning agent to form a coating film, a step of exposing the coating film through a photomask to form a photo-alignment film, and a step of applying polymerizable liquid crystal on the photo-alignment film and hardening the polymerizable liquid crystal to form a liquid crystal layer. The liquid crystal aligning agent contains a polymer having a cinnamate structure, an azobenzene structure or a main chain decomposition type structure. The glass substrate is provided with an alignment mark part serving as an alignment index for the glass substrate on a substrate surface on which the liquid crystal aligning agent is coated. In the scanning exposure, the relative position of the photomask with respect to the alignment mark portion is detected, and the coating film is irradiated with radiation while the relative position of the photomask with respect to the glass substrate is corrected on the basis of the detection result.

The invention provides a fluorescent probe based on a cinnamic acid derivative as well as a synthesis method and application of the fluorescent probe, and relates to the technical field of synthesis of specific probes. The fluorescent probe is a novel bifunctional fluorescent probe capable of specifically detecting Al < 3 + > and N2H4, which is developed by taking p-hydroxycinnamic acid as a raw material and introducing benzyl bromide into a hydroxyl site of a modified structural compound FHA. The probe overcomes the defects in the prior art, can specifically detect Al < 3 + > and N2H4, and has the characteristics of low detection limit, short response time, wide pH application range and the like; and the probe has the characteristics of good biocompatibility, low toxicity, good optical property and the like, and can be applied to cell imaging experiments.

The present invention relates to some crystal forms for a cinnamic compound, BMX, which is an inhibitor of histone deacetylase (HDAC), useful as an agent for the prevention or treatment of diseases associated with HDAC, including for treating tumor or cell proliferative diseases, diabetes mellitus, or neurodegenerative diseases such as Alzheimer's disease, Huntington's disease, Spinocerebellar Ataxias (SCA) and human spinal muscular atrophy (SMA). Also provided are a method for preparing the crystal forms and pharmaceutical compositions comprising the crystal forms.